6078.HK vs. 1177.HK
Compare and contrast key facts about Hygeia Healthcare Holdings Co Ltd (6078.HK) and Sino Biopharmaceutical Ltd (1177.HK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: 6078.HK or 1177.HK.
Key characteristics
| 6078.HK | 1177.HK | |
|---|---|---|
| YTD Return | 4.82% | -17.00% |
| 1Y Return | -35.68% | -30.48% |
| 3Y Return (Ann) | -15.99% | -29.39% |
| Sharpe Ratio | -0.60 | -0.80 |
| Daily Std Dev | 56.11% | 42.32% |
| Max Drawdown | -81.32% | -87.72% |
| Current Drawdown | -65.66% | -84.88% |
Fundamentals
| 6078.HK | 1177.HK | |
|---|---|---|
| Market Cap | HK$20.46B | HK$52.05B |
| EPS | HK$0.00 | HK$0.01 |
| PE Ratio | 27.69 | 25.18 |
| Revenue (TTM) | HK$4.08B | HK$26.20B |
| Gross Profit (TTM) | HK$1.02B | HK$21.53B |
| EBITDA (TTM) | HK$1.00B | HK$6.31B |
Correlation
The correlation between 6078.HK and 1177.HK is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
6078.HK vs. 1177.HK - Performance Comparison
In the year-to-date period, 6078.HK achieves a 4.82% return, which is significantly higher than 1177.HK's -17.00% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
6078.HK vs. 1177.HK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Hygeia Healthcare Holdings Co Ltd (6078.HK) and Sino Biopharmaceutical Ltd (1177.HK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
6078.HK vs. 1177.HK - Dividend Comparison
6078.HK's dividend yield for the trailing twelve months is around 0.44%, less than 1177.HK's 2.78% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
6078.HK Hygeia Healthcare Holdings Co Ltd | 0.44% | 0.46% | 0.00% | 0.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
1177.HK Sino Biopharmaceutical Ltd | 2.78% | 2.31% | 2.19% | 0.73% | 0.71% | 0.37% | 0.77% | 0.22% | 0.49% | 0.25% | 0.27% | 0.24% |
Drawdowns
6078.HK vs. 1177.HK - Drawdown Comparison
The maximum 6078.HK drawdown since its inception was -81.32%, smaller than the maximum 1177.HK drawdown of -87.72%. Use the drawdown chart below to compare losses from any high point for 6078.HK and 1177.HK. For additional features, visit the drawdowns tool.
Volatility
6078.HK vs. 1177.HK - Volatility Comparison
Hygeia Healthcare Holdings Co Ltd (6078.HK) has a higher volatility of 21.19% compared to Sino Biopharmaceutical Ltd (1177.HK) at 15.76%. This indicates that 6078.HK's price experiences larger fluctuations and is considered to be riskier than 1177.HK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
6078.HK vs. 1177.HK - Financials Comparison
This section allows you to compare key financial metrics between Hygeia Healthcare Holdings Co Ltd and Sino Biopharmaceutical Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities